Literature DB >> 7401073

Late mortality in SLE--"the price we pay for control".

M B Urowitz, D D Gladman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7401073

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

1.  The many faces of lupus.

Authors:  H El-Gabalawy
Journal:  Can Fam Physician       Date:  1990-05       Impact factor: 3.275

2.  Prolonged complete remission in previously severe SLE.

Authors:  E C Tozman; M B Urowitz; D D Gladman
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

3.  N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification.

Authors:  Cecilia P Chung; Joseph F Solus; Annette Oeser; Ingrid Avalos; Daniel Kurnik; Paolo Raggi; C Michael Stein
Journal:  J Rheumatol       Date:  2008-06-01       Impact factor: 4.666

4.  Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.

Authors:  E M C Sella; E I Sato; W A Leite; J A Oliveira Filho; A Barbieri
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

5.  Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy, and coronary calcification.

Authors:  Elizabeth Turner; Victor Dishy; Cecilia P Chung; Paul Harris; Rosanna Pierces; Yu Asanuma; Annette Oeser; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; C Michael Stein
Journal:  Vasc Health Risk Manag       Date:  2005

6.  Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease.

Authors:  Hanan Al Rayes; Paula J Harvey; Dafna D Gladman; Jiandong Su; Arthy Sabapathy; Murray B Urowitz; Zahi Touma
Journal:  Arthritis Res Ther       Date:  2017-02-10       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.